Promoting Optimum Health & Happiness



MINIRIN / DDAVP was developed by Ferring Pharmaceuticals. Its active ingredient is desmopressin. MINIRIN / DDAVP is a peptide-based synthetic analogue of human antidiurectic  hormone, vasopressin. MINIRIN / DDAVP mimics the action of vasopressin on the kidneys to increase the reabsorption of water thereby reducing the volume of urine produced while the person sleeps. Cases of bedwetting or Primary Nocturnal Enuresis (PNE)  and Nocturia due to excessive urine production can be treated successfully and safely with MINIRIN / DDAVP.  MINIRIN / DDAVP is fast acting and has a duration of action of a normal night’s sleep.